Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2014-06-04

Clinical Trial Update: Visual Outcomes And Contrast Sensitivity After Myopic Wavefront-Optimized Lasik With Nexisvision Shield Or Bandage Contact Lens [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating visual outcomes and contrast sensitivity after myopic wavefront-optimized LASIK with Nexisvision Shield or a bandage contact…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Durrie Vision | Conditions: Myopia | Phase 4 | Status: WITHDRAWN